Baxion
Screening
Tags
Alerts
Theme
Ironwood Pharmaceuticals Inc.
IRWD
·
NASDAQ
·
$3.90
Share Price as of 11/2
·
$642M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/06/26
10-Q
Q1 ended 03/31/26
05/07/26
10-K
FY 2025
02/26/26
10-Q
Q3 ended 09/30/25
11/10/25
10-Q
Q2 ended 06/30/25
08/11/25
Disclosures
Filter
8-K
Current report
10/16/26
8-K
Current report
08/06/26
8-K
Current report
06/18/26
8-K
Current report
06/15/26
8-K/A
Current report (amended)
05/21/26
Prospectuses and Registrations
Filter
S-3ASR
Automatic shelf registration
11/09/23
S-8
Registration of securities for employees
11/09/23
S-3ASR
Automatic shelf registration
11/06/20
S-8
Registration of securities for employees
05/31/19
S-8
Registration of securities for employees
05/31/19
Proxies
Filter
DEF 14A
Definitive proxy
04/28/26
DEFA14A
Additional proxy materials
04/28/26
DEF 14A
Definitive proxy
04/28/25
DEFA14A
Additional proxy materials
04/28/25
DEF 14A
Definitive proxy
04/25/24
Ownership
Filter
144
Proposed sale of securities
09/23/26
Form 4
Insider transaction
09/17/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
Form 3
Initial insider ownership
07/22/26
Form 4
Insider transaction
07/22/26
Other
Filter
ARS
Annual report to shareholders
04/28/26
ARS
Annual report to shareholders
04/28/25
NT 10-K
Late filing notification (10-K)
03/03/25
ARS
Annual report to shareholders
04/25/24
UPLOAD
Letter from the SEC
12/06/23
Latest Filings
Filter
8-K
Current report
10/16/26
10-Q
Q2 ended 06/30/26
08/06/26
8-K
Current report
08/06/26
8-K
Current report
06/18/26
8-K
Current report
06/15/26
Ownership
Filter
144
Proposed sale of securities
09/23/26
Form 4
Insider transaction
09/17/26
SC 13G/A
Beneficial ownership (amended)
08/14/26
Form 3
Initial insider ownership
07/22/26
Form 4
Insider transaction
07/22/26